Loading
Only a handful of insider records exist for Nymox Pharmaceutical Corporation, the last one from 1 February 2017, too few to describe a trend. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
· cache
1 of 1 declaration
Nymox Pharmaceutical Corporation is a biopharmaceutical company focused on developing treatments for age-related diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.